Keywords: novo, continues, expand, diabetes, focus, alfa, wassermann

Novo Continues To Expand Diabetes Focus With Alfa Wassermann Deal

Article | 03 July 1995

Novo Nordisk has signed an option agreement with a privately-held Italian pharmaceutical company, Alfa Wassermann, regarding the development of new ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Novo Nordisk

Go to company listing